Objective: To explore potential functional biomarkers in diabetes mellitus (DM) by utilizing gene pathway cross-talk. Methods: Firstly, potential disrupted pathways that were enriched by differentially expressed genes (DEGs) were identified based on biological pathways downloaded from the Ingenuity Pathways Analysis (IPA) database. In addition, we quantified the pathway crosstalk for each pair of pathways based on Discriminating Score (DS). Random forest (RF) classification was then employed to find the top 10 pairs of pathways with a high area under the curve (AUC) value between DM samples versus normal samples based on 10-fold cross-validation. Finally, a Monte Carlo Cross-Validation was applied to demonstrate the identified pairs of pathways by a mutual information analysis. Results: A total of 247 DEGs in normal and disease samples were identified. Based on the F-test, 50 disrupted pathways were obtained with false discovery rate (FDR) < 0.01. Simultaneously, after calculating the DS, the top 10 pairs of pathways were selected based on a higher AUC value as measured by RF classification. From the Monte Carlo Cross-Validation, we considered the top 10 pairs of pathways with higher AUC values ranked for all 50 bootstraps as the most frequently detected ones. Conclusion: The pairs of pathways identified in our study might be key regulators in DM.
Introduction
Diabetes mellitus (DM) is one of the most important metabolic dysfunctions which is often asymptomatic in the early stages [1] [2] [3] . More than 300 million people worldwide are suffering with DM. Studies have shown that population aging, changes in lifestyle and improvement in detection techniques are the most important factors resulting in an increased number of cases being identified [4] . DM can frequently cause complications in a number of different organs, including the heart, eyes, kidneys, and nervous system, which has resulted in considerable economic cost and burden. Therefore, the diagnosis of this disease at early stages is very important.
Currently, the integration and biological interpretation of large-scale analysis is a major challenge in bioinformatics research [5] . The rapid development of high-throughput technologies has brought unprecedented opportunity for the large-scale analysis of DM to ascertain key molecular mechanisms and transform the data into a meaningful biological phenomenon. To date, there have been many studies identifying genes related to diabetes, such as PPRAG, IRS1, KCNJ11 and HNFA [6] [7] [8] [9] . However, genes that are not differentially expressed can also be responsible for biological effects since they can exhibit significant coordinated changes. What is worse, relying on differentially expressed gene (DEG) alone may lead to false positives since some genes are not involved in disease-specific pathways. In order to obtain an accurate interpretation of high-throughput genomic experiments, identification of signaling and metabolic pathways is crucial. To our knowledge, most methods consider pathways as independent, and are rarely referred to as involved in cross-talk. Cross-talk among pathways implies a regulatory interaction between the different pathways. More importantly, identification of cross-talk can provide additional functional information for data interpretation and facilitates a better understanding of the connections between two pathways. However, currently there are no reliable methods utilized to quantify cross-talk for paired pathways [10] . Significantly, the combining of DEGs and pathway data with Monte Carlo cross-validation has been considered to quantify the cross-talk between the paired pathways [11] . Monte Carlo cross-validation [12] has been suggested to decrease the risk of overfitting of a model, and has been widely applied to measure the prediction ability of the selected model. Therefore, to reveal novel molecular mechanisms of DM, we compiled microarray expression data and biological pathway information as study objects, and identified potential pathway pairs associated with DM while considering the functional dependency among pathways using Monte Carlo Cross-Validation. We selected DEGs using Differential Expression Analysis (DEA). The biological pathways were downloaded from the Ingenuity Pathways Analysis (IPA) database. Furthermore, we integrated DEGs with the IPA pathways to extract the disrupted pathways bearing a false discovery rate (FDR) < 0.01 based on an F-test. In addition, we calculated the Discriminating Score (DS) for each pair of pathways by quantifying their pathway cross-talk and obtained the top 10 pairs of pathways with area under the curve (AUC) value in descending order based on 10-fold cross-validation. Finally, we verified the procedures via a Monte Carlo Cross-Validation and detected several disrupted pairs of pathways that could serve as the potential biomarkers for the diagnosis of DM.
Materials and Methods

Data collection
In the present study, the gene expression dataset (accession number: E-GEOD-35725) [13] was downloaded from the ArrayExpress Archive of Functional Genomics Data (http://www.ebi.ac.uk/arrayexpress/) which is an international functional genomics database at the European Bioinformatics Institute (EMBL-EBI). This data was derived from samples that were analyzed by the platform of A-AFFY-44 -Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]. In the E-GEOD-35725, there were 7 autologous plasma, 44 unrelated healthy control plasma, 63 DM patients (46 recent onset T1D plasma, 11 longstanding T1D plasma, and 6 longitudinal series plasma from pre/post onset). In our study, to explore the etiology of DM, only 63 DM patients and 44 controls were selected to perform the subsequent analysis.
Data preprocessing
When obtaining the microarray data, repeated probes were eliminated first. Additionally, we aligned the probes to the gene symbol and removed duplicates. Ultimately, there were 20544 genes identified for further analysis.
Detection of DEGs
We utilized a quantile based algorithm [14] to perform standard processing for the gene expression data. Across all samples, we selected genes with a mean value higher than the 0.25 * quantile mean. Furthermore, we used quantile-adjusted conditional maximum likelihood (qCML) method [15] involved in the edgeR package to analyze genes that were differentially expressed. Compared with several other estimators, qCML is most reliable in terms of bias on a wide range of conditions, and specifically performs best in the situation of many small samples with a common dispersion. Next, we corrected the P-value into FDR by Benjamini-Hochberg [16] . In this research, we screened out the genes as the DEGs under the threshold of FDR < 0.01.
Analysis of disrupted pathways
For the purpose of exploring the enrichment of pathways, further analysis was performed for DEGs using IPA software. Primarily, we downloaded 589 biological pathways including 20,038 genes derived from the IPA (http://www.ingenuity.com/) tool. We then mapped DEGs to corresponding IPA pathways. Consequently, we conducted an F-test for the DEGs and the genes of each IPA pathway to obtain a P-value of each pathway. In addition, the P-value was adjusted using the Benjamini-Hochberg method. Furthermore, we screened the disrupted pathways displaying an FDR < 0.01.
Extraction of pathway cross-talk based on DS value
For all genes in each pathway, we calculated the mean value and standard deviation. We computed it's DS value [17] , followed by construction of pairs of pathways for each of the two disrupted pathways. DS score reflects the relationships between pairs of pathways, with a greater value indicating relatively higher difference of activity between pathways. The formula is defined as follows:
M a and S a represent the mean and standard deviation of genes expression levels in pathway a, M b and S b represent the mean and standard deviation of expression levels of genes in pathway b.
Selection of the pathways pairs
Random forest (RF) is a machine learning algorithm used for classification and has the ability to efficiently handle high dimensionality and highly correlated data [18] . It's high predictive power has been supported by previous comparative studies with other machine learning (ML) methods [19] [20] [21] . The final classification is obtained by combining the classification results from the individual decision trees. Briefly, RF builds a collection of decision trees based on randomly and independently selected subsets of data, and a simple majority vote among all trees in the forest is taken for class prediction.
In this study, we trained the RF prediction model to identify specific disrupted pathways potentially associated with diabetes mellitus based on the DS values for each sample in order to classify the DM and control samples. Specifically, we performed 10-fold cross-validation to calculate the AUC values to further randomly classify the normal group and the disease group through adopting the following parameters: mtry and ntree. The value of mtry (number of variables randomly sampled as candidates at each split) was equal to sqrt(p); p denoted the count of variables in the matrix of data; ntree (number of trees grown) was equivalent to 500. Based on the identified AUC of each pair of pathways via the RF-based method, we ranked all AUC scores in descending order, and further screened out the top 10 disrupted pairs of pathways.
Monte Carlo Cross-Validation
As described previously, for validation analysis, the sample size in the training set is generally bigger than that in the testing set. Significantly, the ratio of 6 to 4 is a commonly used proportion. A previous study randomly selected 60% as the training set and the remaining 40% as the testing data [22] . Thus, in our study, we utilized the Monte Carlo Cross-Validation to randomly form the training set and the testing set according to the proportion of 6:4. Similar to previous analyses, we repeated 50 times, generating randomly new training and test partitions each time. Moreover, we generated new DEGs, disrupted pathways and a DS score for pairs of pathways each time. Likewise, the top 10 pairs of pathways were considered via the AUC value each time that obtained the best classification performance in the training set. Meanwhile, the testing set was used to validate the top 10 pairs of pathways in each time. Finally, all AUC values were ranked in descending order, and from this, we selected the top 10 disrupted pairs of pathways.
Results
Analysis of disrupted pathway
After removing repeating probes, there were 20,544 genes in all samples. Furthermore, based on the quantile method, we obtained 15,408 genes with a mean value greater than the 0.25 * quantile mean. After conducting the quantileadjusted conditional maximum likelihood method for these genes, we identified 247 DEGs possesing FDR < 0.01. Using the F-test for genes in the IPA pathway, as well as the DEGs, a list of 50 significantly pathways were presented with an FDR score < 0.01. The result is shown in Table 1 . Subsequently, a DS was counted through comparing the expression levels of each pair of pathways involved in DEGs in each sample. The distribution of DS values is shown in Supplemental Table 1 . With a larger DS we also observed a greater difference of activity between the pathway pairs. Remarkably, the DS values of 3 instances of pathway cross-talk were greater than 2, including the pathway pair of Choline Biosynthesis III and DNA DoubleStrand Break Repair by Homologous Recombination (DS = 2.562766), Choline Biosynthesis III and DNA DoubleStrand Break Repair by Non-Homologous End Joining (DS = 2.275759), and IL-9 Signaling and Choline Biosynthesis III (DS = 2.019939).
Selection of the best pairs of pathways in DM
Pairs of pathways were selected after 50 cycles and used to generate a heat map. The pathway pairs with an occurrence number > 4 are shown in Figure 1 . More importantly, these pairs of pathways were ranked in descending order on the basis of AUC value, and the top 10 disrupted pairs of pathways are displayed in Table 2 . We observed the following disrupted pairs of pathways with AUC value > 0.85 appeared in multiple cycles: (1) CD40 signaling and CD28 signaling in T helper cells; (2) HMGB1 signaling and role for hypercytokinemia/hyperchemokinemia in the pathogenesis of influenza; (3) CD40 signaling and PKC_ signaling in T lymphocytes.
Discussion
DM is a group of metabolic diseases in which there are high blood sugar levels for a prolonged period. From 2012 to 2014, diabetes is estimated to have resulted in 1.5 to 4.9 million deaths each year [23) ]. The number of people with diabetes is expected to rise to 592 million by 2035 [24] . Hence, seeking an effective approach to prevent and treat DM is particularly important. In this context, we proposed a comprehensive approach to elucidate pathway cross-talk associated with DM. Our analysis incorporated disrupted pairs of pathways and the RF classification. Quantitative values from a series of functional genes identified in each pathway can be used to generate biological interaction pathway pairs which provide a more integrated view of the biological mechanisms of DM. As a result, we constructed a more comprehensive view of the underlying regulatory mechanisms of DM through analysis of disrupted pairs of pathways. In addition, we validated the top 10 disrupted pathways of DM by Monte Carlo Cross-Validation. It verified the accuracy of the proposed method for analyzing the disrupted pairs of pathways of disease. Finally, we identified that the pair of pathways CD40 signaling and CD28 signaling in T Helper Cell appeared most frequently (frequency of occurrence = 47) with AUC value < 0.85.
CD40 is a cell surface receptor important in the activation of antigen-presenting cells during immune responses. CD40 signaling in professional antigenpresenting cells, including B cells, macrophages, and dendritic cells, is critical for the efficient activation of humoral and cell-mediated immune responses [25] [26] [27] . It was verified that CD40 signaling pathway represents a good example of a pathway for which human genetics helped to guide drug development in rheumatoid arthritis [28] . Additionally, another study has shown that CD40 pathway activation status may predict the antitumor activity of CD40-stimulating therapeutic drugs [29] . Moreover, it has been proposed that the soluble CD40L/ CD40 pathway is related to inflammation and vascular diseases [30] . In particular, other studies have indicated that CD40 signaling promotes autoimmunity in type 1 diabetes [31] . There is no inclusive information for CD28 signaling in T helper cell in DM. Fortunately, Shin et al. [32] have provided information that CD28 signaling in T helper cells was reduced following Mycobacterium avium subsp. paratuberculosis infection. Through our analysis, CD28 signaling in T helper cells is proposed as a novel biomarker for DM. Moreover, we demonstrated a link between CD40 signaling and CD28 signaling in T helper cells, as its frequency of occurrence = 47 and AUC = 0.862, which was an important pair of pathways in DM. In the current study, DS values were used to quantify the cross-talk among pathways. Additionally, we investigated several pairs of pathways by Monte Carlo Cross-Validation analysis, with potential diagnostic and therapeutic roles relating to DM. On the basis of these results, we concluded that the method used in our research can accurately classify aggressive DM versus normal samples. These pairs of pathways might be potential biomarkers for early detection and therapy for DM.
